Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 2
2011 1
2012 2
2013 4
2014 3
2015 3
2016 1
2017 3
2018 3
2019 7
2020 11
2021 12
2022 7
2023 16
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Long non-coding RNAs in breast cancer stem cells.
Huang Y, Mo W, Ding X, Ding Y. Huang Y, et al. Among authors: ding y. Med Oncol. 2023 May 13;40(6):177. doi: 10.1007/s12032-023-02046-1. Med Oncol. 2023. PMID: 37178429 Review.
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
Tang S, Wang Y, Luo R, Fang R, Liu Y, Xiang H, Ran P, Tong Y, Sun M, Tan S, Huang W, Huang J, Lv J, Xu N, Yao Z, Zhang Q, Xu Z, Yue X, Yu Z, Akesu S, Ding Y, Xu C, Lu W, Zhou Y, Hou Y, Ding C. Tang S, et al. Among authors: ding y. Nat Commun. 2024 Feb 15;15(1):1381. doi: 10.1038/s41467-024-45306-y. Nat Commun. 2024. PMID: 38360860 Free PMC article.
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Ding Y, Mo W, Xie X, Wang O, He X, Zhao S, Gu X, Liang C, Qin C, Ding K, Yang H, Ding X. Ding Y, et al. Oncol Res Treat. 2023;46(7-8):303-311. doi: 10.1159/000531492. Epub 2023 Jun 9. Oncol Res Treat. 2023. PMID: 37302393 Clinical Trial.
69 results